BCAX insider buying – Bicara Therapeutics Inc.
3 insider purchases since 2016 worth $39.1M by 3 different insiders. Last 12 months: 1 purchases, $4.8M. Most recent filing: 2026-03-02.
Mid company Public float $377M (latest 10-K, SEC).
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| RA Capital Nexus Fund III, L.P. Director | $33.0M 1× · 1,833,000 sh | 2024-09-16 2024-09-16 | – | 2,622,898 shares as of 2024-09-18 | Holds - never sold |
| RA CAPITAL MANAGEMENT, L.P. Director | $4.8M 1× · 300,000 sh | 2026-02-26 2026-02-26 | – | 4,603,418 shares as of 2026-03-02 | Holds - never sold |
| Deerfield Private Design Fund V, L.P. 10% Owner | $1.3M 1× · 70,000 sh | 2024-09-17 2024-09-17 | – | 1,795,174 shares as of 2024-09-17 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 1 | $4.8M | 1 | 25 | $7.9M |
| 2025 | 0 | – | – | 17 | $7.0M |
| 2024 | 2 | $34.3M | 2 | – | – |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-02 | RA CAPITAL MANAGEMENT, L.P. | Director | 300,000 | $16.00 | $4.8M | +7.0% | SEC |
| 2024-09-18 | RA Capital Nexus Fund III, L.P. | Director | 1,833,000 | $18.00 | $33.0M | +74.2% | SEC |
| 2024-09-17 | Deerfield Private Design Fund V, L.P. | 10% Owner | 70,000 | $18.00 | $1.3M | +8.5% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | Cohlhepp Ryan | CEO | 17,500 | $22.90 | $400,747 | Pre-planned (10b5-1) | SEC |
| 2026-08-12 | Mazumdar Claire | CEO | 10,000 | $27.98 | $279,800 | Pre-planned (10b5-1) | SEC |
| 2026-08-12 | Hyep Ivan | CFO | 12,500 | $27.97 | $349,625 | Pre-planned (10b5-1) | SEC |
| 2026-08-12 | Cohlhepp Ryan | CEO | 18,750 | $27.98 | $524,625 | Pre-planned (10b5-1) | SEC |
| 2026-07-14 | Mazumdar Claire | CEO | 10,000 | $28.42 | $284,235 | Pre-planned (10b5-1) | SEC |
| 2026-07-10 | Hyep Ivan | CFO | 28,000 | $28.84 | $807,603 | Pre-planned (10b5-1) | SEC |
| 2026-07-10 | Cohlhepp Ryan | CEO | 28,750 | $28.98 | $833,166 | Pre-planned (10b5-1) | SEC |
| 2026-05-26 | Hyep Ivan | CFO | 9,200 | $20.42 | $187,864 | Pre-planned (10b5-1) | SEC |
| 2026-05-20 | Mazumdar Claire | CEO | 15,000 | $20.04 | $300,561 | Pre-planned (10b5-1) | SEC |
| 2026-05-18 | Cohlhepp Ryan | CEO | 12,500 | $20.29 | $253,625 | Pre-planned (10b5-1) | SEC |
| 2026-04-28 | Raben David | Officer | 5,500 | $22.88 | $125,840 | Pre-planned (10b5-1) | SEC |
| 2026-04-22 | Hyep Ivan | CFO | 9,200 | $23.00 | $211,600 | Pre-planned (10b5-1) | SEC |
| 2026-04-20 | Mazumdar Claire | CEO | 15,000 | $23.61 | $354,150 | Pre-planned (10b5-1) | SEC |
| 2026-04-17 | Cohlhepp Ryan | CEO | 12,500 | $23.01 | $287,625 | Pre-planned (10b5-1) | SEC |
| 2026-03-26 | Raben David | Officer | 5,500 | $18.95 | $104,225 | Pre-planned (10b5-1) | SEC |
Showing the latest 15 of 42 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free